Ethylene

Ethylene

SCHEMBL6508802

C=C.O=C1CCn2c(N3CCN(c4ccc(O)cc4)CC3)nc3cccc1c32

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.39
ALDH1A1 P00352 4/20 0.39
LMNA P02545 3/20 0.39
GFER P55789 1/20 0.39
DRD4 P21917 1/20 0.38
USP2 O75604 2/20 0.36
NPC1 O15118 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 2/20 0.34
HTT P42858 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TSHR P16473 1/20 0.34
METAP1 P53582 1/20 0.34
MAPT P10636 3/20 0.34
PARP1 P09874 1/20 0.34
HPGD P15428 1/20 0.34
GBA1 P04062 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509219 0.98 GAA (0.41) GAAALDH1A1LMNAGFERDRD4
SCHEMBL6630480 0.86 MAPT (0.40) GAAALDH1A1LMNAGFERUSP2
Hydrochloric Acid SCHEMBL6505881 0.85 MAPT (0.39) GAAALDH1A1LMNAGFERUSP2
SCHEMBL6630043 0.85 PARP1 (0.38) ALDH1A1USP2SMN1; SMN2KDM4EHTT
Hydrochloric Acid SCHEMBL6503053 0.84 PARP1 (0.38) ALDH1A1USP2SMN1; SMN2KDM4EHTT
SCHEMBL6631403 0.83 MAPT (0.45) GAAALDH1A1LMNANPC1MEN1
SCHEMBL6505984 0.83 PARP1 (0.36) GAAALDH1A1LMNAUSP2NPC1
Ethylene SCHEMBL6503293 0.83 MAPT (0.44) ALDH1A1LMNANPC1SMN1; SMN2KDM4E
SCHEMBL6503698 0.82 GFER (0.48) GAAALDH1A1LMNAGFERUSP2
SCHEMBL6656878 0.80 ALDH1A1 (0.43) ALDH1A1LMNANPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032779-A1 Benzimidazole derivatives, preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2005-02-10 US disclosed
US-6794382-B2 6-OXO-5,6-DIHYDRO-4H-IMIDAZO(4,5,1-IJ)QUINOLINE DERIVATIVES AS INHIBITORS OF ADP-RIBOSYLTRANSFERASE; CARDIOVASCULAR, IMMUNOLOGICAL, RESPIRATORY SYSTEM, AND NEURODEGENERATIVE DISORDER TREATMENT SANOFI-SYNTHELABO (FR) 2004-09-21 US disclosed
US-20030203893-A1 Benzimidazole derivatives, preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032779-A1 Benzimidazole derivatives, preparation and therapeutic use thereof CBR3, CYP3A7, HDAC7 GAA 3044/4885ALDH1A1 4006/4885LMNA 2282/4885
US-20030203893-A1 Benzimidazole derivatives, preparation and therapeutic use thereof CBR3, HRH4, CBR1 GAA 3140/4885ALDH1A1 3413/4885LMNA 2723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.